5 Cannabis Stocks Under $5

HENDERSON, NV / ACCESSWIRE / February 1, 2019 / With ArcView predicting the worldwide legal cannabis market will reach $57 billion by 2027, it’s no wonder investors are flocking to companies in the industry. Companies like Canopy Growth, Cronos Group, and Tilray have made investors big money, making big moves. Today, we decided to highlight a few cannabis plays under $5 a share with a ton of upside potential that could be the next big success story in the sector.

One we think has explosive growth potential is Real Brands, Inc. (RLBD). The company is launching a CBD beverage called Omegahemp™ Water. RLBD has strong management with a solid background in branding and the beverage industry and plans to expand their holdings focusing on at least three CBD Categories: smokables, edibles and topical balms and lotions. The time to research on RLBD is now; the company just announced it acquired the trademarks: Humboldt Brands®, Hemp-Aid® and HempAid®. This could be a sign of more news to come.

Today we are highlighting: Real Brands, Inc. (RLBD), Emerald Health Therapeutics, Inc. (EMHTF), The Green Organic Dutchman (TGODF), The Alkaline Water Company (WTER), and MedMen Enterprises, Inc. (MMNFF).

Real Brands, Inc. (RLBD) (Market Cap: $19.449M, Share Price: $0.1469) is launching a CBD beverage called Omegahempâ„¢ Water.

The company just announced that they have engaged an accounting firm that is registered with the Public Company Accounting Oversight Board (PCAOB) to complete their two-year audit which could make the company desirable to larger investors.

The company is could be close to its first production run, meaning there could be major news on the way. The audit on the horizon means this could also be another major event that sends this company to the stratosphere. Now's the time to research RLBD.

_____

Emerald Health Therapeutics, Inc. (EMHTF) (Market Cap: $375.624M, Share Price: $2.66) announced it will launch its award-winning Endo products in Whole Foods Markets across the United States, highlighting the unique positioning and opportunity for this product line when it is launched in Canada in 2019.

_____

The Green Organic Dutchman (TGODF) (Market Cap: $721.247M, Share Price: $2.68) announced that the Danish Medicines Agency, the Government body responsible for issuing cannabis related licenses, has granted an initial cannabis business authorization to TGODF's joint venture production partner Knud Jepsen. This licence will allow TGOD's JV partner Kund Jepsen to immediately begin importation of starting materials and to begin research and development related to the creation of elite cannabis genetics.

_____

The Alkaline Water Company (WTER) (Market Cap: $115.975M, Share Price: $3.40) has announced their A88 Infused division focused bioactive natural hemp extract molecules to U.S. consumers.

_____

MedMen Enterprises, Inc. (MMNFF) (Market Cap: $1.641B, Share Price: $3.54) announced that Treehouse Real Estate Investment Trust has completed its first round of capital raise at $133 million and will partially use the funds to purchase properties from the Company.

Legal Disclaimer:

This article was written by Regal Consulting, LLC ("Regal Consulting"). Regal Consulting has agreed to a three-month term consulting agreement with RLBD dated 8/31/18. The agreement calls for $100,000 note issued to Regal Consulting, and 2,500,000 restricted 144 shares of RLBD for three months of service. Regal has elected to convert $73,000 of principal of the $100,000 note into 2,761,872 Restricted 144 shares of RLBD. Regal Consulting has agreed to a twelve- month term consulting agreement with RLBD dated 1/4/2019. The agreement calls for $10,000 in cash and 500,000 shares per month. All payments were made directly by Real Brands, Inc. to Regal Consulting, LLC. to provide investor relations services, of which this article is a part of. Regal Consulting also paid one thousand dollars cash to microcapspecultors.com to distribute this article. Regal Consulting may have a position in the securities mentioned in this article at the time of publication, and may increase or decrease its position without notice. This article is based on public information and the opinions of Regal Consulting. RLBD was given an opportunity to edit this article. This article contains forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any results predicted herein. Regal Consulting is not registered with any financial or securities regulatory authority, and does not provide or claim to provide investment advice.